Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Abbott Next Generation Drug Eluting Stent 48mm Study [NA]
Abbott's next-generation 48mm drug-eluting stent study has completed, and results have been posted. The study addressed treatment of coronar…
-
FDA approval · 2024-02-08FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors [Phase 2]
Phase 2 proof-of-activity study of Orticumab in subjects with psoriasis and cardiometabolic risk factors completed.
-
CLINICAL_TRIALS trial_result · 2024-02-01Clinical Trial Update: Disrupt CAD III Post-Approval Study (PAS)
Post-approval study update for Disrupt CAD III; completed with results posted in February 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) [Phase 1, Phase 2]
Clinical trial update on epicardial delivery of XC001 gene therapy for refractory angina in the EXACT trial (Phase 1/2), completed to date.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures [Phase 4]
Phase 4 trial update evaluating uninterrupted direct-acting oral anticoagulation during transradial percutaneous coronary procedures.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment Strategy [Phase 4]
Phase 4 trial update reporting pharmacodynamic outcomes for coronary artery disease patients treated with an individualized treatment strate…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: NOAC Therapy Guided by PARIS Risk Score and D-dimer in Patients With ACS After PCI [Phase 4]
Phase 4 clinical trial evaluating NOAC therapy guided by PARIS risk score and D-dimer in patients with acute coronary syndrome after PCI.
-
CLINICAL_TRIALS trial_result · 2024-01-08Clinical Trial Update: Dynamic Coronary Roadmap for Contrast Reduction [NA]
Clinical trial update for a study on Dynamic Coronary Roadmap aiming to reduce contrast use in coronary artery disease; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization [NA]
A completed randomized clinical trial evaluating diagnostic evaluation and revascularization strategies for coronary artery disease; results…
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Etomidate Versus Propofol in CABG Surgery [Phase 4]
Phase 4 clinical trial comparing etomidate versus propofol in CABG surgery for coronary artery disease.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations [NA]
Clinical trial evaluating diagnostic examinations in patients with stable angina has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-26Clinical Trial Update: Impact of Ranolazine on Coronary Microcirculatory Resistance [NA]
A completed clinical trial evaluating the impact of ranolazine on coronary microcirculatory resistance; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Role of Sugammadex as Reversal Agent in Patients Extubated Immediately After Isolated Coronary Artery Bypass Grafting Surgery [Phase 4]
A Phase 4 clinical trial evaluating sugammadex as a reversal agent for patients extubated immediately after isolated coronary artery bypass …
-
CLINICAL_TRIALS trial_result · 2023-12-08Clinical Trial Update: Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions
A clinical trial for a novel facilitated antegrade steering technique in revascularization of coronary chronic total occlusions has been ter…
-
FDA approval · 2023-12-05FDA Approved: NITROGLYCERIN — Original Application (Lifestar Pharma LLC)
FDA approved an original application for nitroglycerin from Lifestar Pharma LLC, enabling a generic nitroglycerin product.
-
CLINICAL_TRIALS trial_result · 2023-12-04Clinical Trial Update: Glutamate for Metabolic Intervention in Coronary Surgery II [Phase 3]
Phase 3 clinical trial update on glutamate-based metabolic intervention in coronary surgery completed with posted results.
-
FDA approval · 2023-11-21FDA Approved: BIVALIRUDIN — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for bivalirudin from Dr. Reddy's Laboratories Limited, indicating an approved change to an exist…
-
CLINICAL_TRIALS research · 2023-11-18Clinical Trial Update: Genomic Outcomes of Metformin [Phase 4]
A Phase 4 trial assessing genomic outcomes of metformin in adults with coronary artery disease and mild cognitive impairment, with results p…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque [Phase 4]
Phase 4 trial update comparing preventive percutaneous coronary intervention (PCI) to medical therapy alone for vulnerable atherosclerotic c…
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF [Phase 3]
A Phase 3 trial evaluated glutamine as a myocardial protector in elective on-pump CABG surgery for patients with low ejection fraction; the …
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: The Val-CARD Trial [Phase 1, Phase 2]
A clinical trial update for the Val-CARD Trial spanning Phase 1 and Phase 2; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery [NA]
A completed clinical trial evaluating prophylactic maze procedure to prevent atrial fibrillation after adult cardiac surgery; results posted…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Rivaroxaban Monotherapy After CYP2C19 Genotype Testing in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention [Phase 4]
Phase 4 trial evaluating rivaroxaban monotherapy after CYP2C19 genotype-guided management in patients with atrial fibrillation and coronary …
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: DESyne X2 Post Market Follow-up Study [NA]
Post-market follow-up study update for the DESyne X2 device; the trial was terminated and results posted in 2023.